
Spansules Formulations India Private Limited
Pharmaceutical company specializing in pellet manufacturing for various medications.
Pharmaceutical company specializing in pellet manufacturing for various medications.
Spansules Formulations India Private Limited (SFIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2022 (Three years and two months 0 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.54 Cr.
The company currently has active open charges totaling ₹31.89 Cr.
Rama Guttikonda, Haswanth Guttikonda, Harika Guttikonda, and One other member serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24230TG2022PTC160441
160441
Private Limited Indian Non-Government Company
09 Mar 2022
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Haswanth Guttikonda ![]() | Director | 09-Mar-2022 | Current |
Rama Guttikonda ![]() | Director | 09-Mar-2022 | Current |
Harika Guttikonda ![]() | Director | 09-Mar-2022 | Current |
Venkata Guttikonda ![]() | Director | 09-Mar-2022 | Current |
Spansules Formulations India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2023, Spansules Formulations India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Haswanth Guttikonda and Harika Guttikonda are mutual person
Venkata Guttikonda is a mutual person
Rama Guttikonda, Haswanth Guttikonda and 2 more are mutual person
Rama Guttikonda and Haswanth Guttikonda are mutual person
Rama Guttikonda, Haswanth Guttikonda and 2 more are mutual person
Haswanth Guttikonda and Venkata Guttikonda are mutual person
₹31.89 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
12 Jan 2024 | Hdfc Bank Limited | ₹1.50 M | Open |
25 May 2023 | Axis Bank Limited | ₹2.50 Cr | Open |
01 Oct 2022 | Hdfc Bank Limited | ₹28.44 Cr | Open |
10 Jun 2022 | Hdfc Bank Limited | ₹8.01 M | Open |
Spansules Formulations India has a workforce of 57 employees as of May 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spansules Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansules Formulations India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Spansules Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Spansules Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100862495 was registered on 12 Jan 2024.
A charge with Axis Bank Limited amounted to Rs. 2.50 Cr with Charge ID 100725614 was registered on 25 May 2023.
A charge with Hdfc Bank Limited of Rs. 28.44 Cr registered on 01 Oct 2022 with Charge ID 100629886 was modified on 21 Apr 2023.
A charge with Hdfc Bank Limited amounted to Rs. 28.44 Cr with Charge ID 100629886 was registered on 01 Oct 2022.
Spansules Formulations India Private Limited was incorporated on 09 Mar 2022.
The authorized share capital of Spansules Formulations India Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 9.54 Cr.
Currently 4 directors are associated with Spansules Formulations India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Spansules Formulations India Private Limited is 3Rd Floor Mig-57 Dharma Reddy Colony Hyder Nagar, Kukatpally India, Hyderabad, Telangana, 500072.
The corporate identification number (CIN) of Spansules Formulations India Private Limited is U24230TG2022PTC160441 and the company number is 160441 as per Ministry of Corporate Affairs (MCA).
As Per 2023 financial reports, 57 employees are currently employed by Spansules Formulations India Private Limited.
As per the financial statements for fiscal Year 2023, The total open charges for Spansules Formulations India Private Limited amount to ₹ 31.89 Cr.
The most recent Balance Sheet for Spansules Formulations India Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.